Concomitant T-cell prolymphocytic leukemia and visceral leishmaniasis A case report

被引:0
|
作者
Liao, Hongyan [1 ]
Jin, Yongmei [1 ]
Yu, Jiang [1 ]
Jiang, Nenggang [1 ]
机构
[1] Sichuan Univ, Dept Lab Med, West China Hosp, 37 Guoxue Xiang, Chengdu 610041, Sichuan, Peoples R China
基金
中国博士后科学基金;
关键词
diagnosis; immunophenotype; morphology; T-cell prolymphocytic leukemia; visceral leishmaniasis;
D O I
10.1097/MD.0000000000012410
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: T-cell prolymphocytic leukaemia (T-PLL) is a rare aggressive lymphoid disease featured by a significant increased lymphocyte count and obvious hepatosplenomegaly with poor prognosis. The concomitant presentation of T-PLL and visceral leishmaniasis (VL) has not previously been reported. Patient concerns: The patient initially suffered from anorexia, skin pigmentation, fever and hepatosplenomegaly. Bone marrow smear described leishmania and antibody test was positive. VL was diagnosed and he was given antimony gluconate therapy. His symptoms recurred. Diagnosis: A combination of serological rk39 test, morphologic evaluation and immunophenotyping by flow cytometry finally supported the diagnosis of concomitant VL and T-PLL. Outcomes: Amphotericin B was used for the treatment of VL first and a referral for treating T-PLL after recovery from VL was suggested. Unfortunately, the patient requested to be discharged. Telephone follow-up indicated that he died a few days after leaving the hospital. Lessons: Due to the rarity of the disease combination, the pathogenesis association of T-PLL and VL is unclear. However, a duly diagnosis is crucial for treatment. In immunosuppressed patients due to malignancies and treatment, VL should be considered as an opportunistic infection. In VL infections, the clinical manifestations mimicking hematological malignancies may cover up the underlying disease. Under such conditions, a complete work-up based on laboratory test is necessary to achieve a correct diagnosis.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Cutaneous Presentation of T-Cell Prolymphocytic Leukemia Mimicking Dermatomyositis
    Ingrasci, Giuseppe
    Diaz-Perez, Julio
    Verne, Sebastian
    Romanelli, Paolo
    Yosipovitch, Gil
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2021, 43 (07) : 521 - 524
  • [22] T-cell prolymphocytic leukemia presenting as an ear canal mass
    Adelson, RT
    Samy, RN
    Lindberg, T
    OTOLOGY & NEUROTOLOGY, 2004, 25 (06) : 1006 - 1008
  • [23] T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches
    Ramos, Ana Colon
    Tarekegn, Kidist
    Aujla, Amandeep
    de de Jesus, Katherine Garcia
    Gupta, Sachin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [24] COST-EFFECTIVENESS OF ALEMTUZUMAB FOR T-CELL PROLYMPHOCYTIC LEUKEMIA
    Lu, Lanting
    Peters, Jaime
    Roome, Chris
    Stein, Ken
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (03) : 241 - 248
  • [25] Visceral Leishmaniasis and Glomerulonephritis: A Case Report
    Alwazzeh, Marwan Jabr
    Alhashimalsayed, Zaki Hajji
    SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2019, 7 (01): : 40 - 43
  • [26] Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature
    Tatarelli, P.
    Fornaro, G.
    Del Bono, V.
    Nicolini, L. A.
    Raiola, A. M.
    Gualandi, F.
    Varaldo, R.
    Di Muccio, T.
    Gramiccia, M.
    Gradoni, L.
    Angelucci, E.
    Viscoli, C.
    Mikulska, M.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (12) : 990 - 994
  • [27] Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan
    Yamaguchi, Motoko
    Fukuhara, Noriko
    Takizawa, Jun
    Ishitsuka, Kenji
    Yokohama, Akihiko
    Miyazaki, Kana
    Nato, Yuma
    Ichikawa, Satoshi
    Mitobe, Masaki
    Shima, Kodai
    Miyazawa, Yuri
    Izutsu, Koji
    Suzuki, Ritsuro
    Nagai, Hirokazu
    Nakamura, Naoya
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2024, 64 (03) : 216 - 222
  • [28] What to Look Out for when Transplanting T-Cell Prolymphocytic Leukemia
    Wahnschaffe, Linus
    Herling, Marco
    ACTA HAEMATOLOGICA, 2021, 144 (01) : 1 - 3
  • [29] Cutaneous involvement by T-cell prolymphocytic leukemia presenting as livedoid vasculopathy
    Leckey, Bruce D.
    Kheterpal, Meenal K.
    Selim, M. Angelica
    Al-Rohil, Rami N.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2021, 48 (07) : 975 - 979
  • [30] T-cell prolymphocytic leukemia with autoimmune manifestations in Nijmegen breakage syndrome
    Michallet, AS
    Lesca, G
    Radford-Weiss, I
    Delarue, R
    Varet, B
    Buzyn, A
    ANNALS OF HEMATOLOGY, 2003, 82 (08) : 515 - 517